Chemoinformaics analysis of Jusmicranthin ethyl ether
| Molecular Weight | 392.363 | nRot | 3 |
| Heavy Atom Molecular Weight | 376.235 | nRig | 30 |
| Exact Molecular Weight | 392.09 | nRing | 6 |
| Solubility: LogS | -5.864 | nHRing | 3 |
| Solubility: LogP | 4.163 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 3 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 17 |
| nHA | 7 | APOL | 53.0227 |
| nHD | 0 | BPOL | 27.3353 |
| QED | 0.62 |
| Synth | 3.355 |
| Natural Product Likeliness | 1.029 |
| NR-PPAR-gamma | 0.019 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.725 |
| Pgp-sub | 0 |
| HIA | 0.001 |
| CACO-2 | -4.824 |
| MDCK | 0.0000653 |
| BBB | 0.039 |
| PPB | 0.970611 |
| VDSS | 0.568 |
| FU | 0.00841325 |
| CYP1A2-inh | 0.909 |
| CYP1A2-sub | 0.169 |
| CYP2c19-inh | 0.967 |
| CYP2c19-sub | 0.08 |
| CYP2c9-inh | 0.882 |
| CYP2c9-sub | 0.916 |
| CYP2d6-inh | 0.904 |
| CYP2d6-sub | 0.897 |
| CYP3a4-inh | 0.837 |
| CYP3a4-sub | 0.097 |
| CL | 11.309 |
| T12 | 0.101 |
| hERG | 0.026 |
| Ames | 0.827 |
| ROA | 0.011 |
| SkinSen | 0.485 |
| Carcinogencity | 0.969 |
| EI | 0.112 |
| Respiratory | 0.422 |
| NR-Aromatase | 0.353 |
| Antiviral | Yes |
| Prediction | 0.741198 |